Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study

BackgroundFibroblast growth factor 23 (FGF23) is emerging as a novel biomarker of bone metabolism, chronic kidney disease, and cardiovascular disease (CVD). However, its clinical correlates and potential predictive role in a community‐based setting are incompletely understood. Methods and ResultsWe...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Robin Haring, Danielle Enserro, Vanessa Xanthakis, Gary F. Mitchell, Emelia J. Benjamin, Naomi M. Hamburg, Lisa Sullivan, Matthias Nauck, Henri Wallaschofski, Ramachandran S. Vasan
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Wiley 2016-07-01
Seri Bilgileri:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Konular:
cardiovascular disease risk factors
epidemiology
metabolism
mineral
Online Erişim:https://www.ahajournals.org/doi/10.1161/JAHA.116.003486

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.003486

Benzer Materyaller